Skip to content

Antihypertensive effect andregulation mechanism of VA intervention

Antihypertensive effect andregulation mechanism of VA intervention

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-15007111
Enrollment
Unknown
Registered
2015-09-20
Start date
2016-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension in children

Interventions

VA group:VA supplementation
VA+health education group:VA+health education
health education group:health education
VD group:VD supplementation

Sponsors

Childrens Hospital, Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1. Han nationality; 2. Blood pressure level reached the diagnostic criteria of hypertension, SBP<150 andDBP<100; 3. Didnt take antihypertensive drugs; 4. Age 6 - 12 years; 5.Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Taking antihypertensive drugs; 2. Hypertension with obvious clinical symptoms; 3. Secondary hypertension; 4. Severe kidney, diabetes, cardiovascular disease, endocrine disease; 5. The guardian refused to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
systolic blood pressure;diastolic blood pressure;Vitamin A concentration;blood glucose;blood lipid;Ang II level;

Countries

China

Contacts

Public ContactXiaohua Liang
936241976@qq.com+86 15086744361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026